Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2025 09:42 ET | Source: Research and Markets

Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 06, 2025 10:27 ET | Source: Research and Markets

Ventricular Hypertrophy Industry Growth Report Report 2025-2035 - Advancements in Telemedicine Presenting New Avenues for Remote Patient Management

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Ventricular Hypertrophy Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035" has...
October 31, 2025 05:26 ET | Source: Research and Markets

Atrial Fibrillation Eight-Market Drug Forecast and Market Analysis 2022-2024 & 2025-2032: Market to Remain Dominated by Bayer and Bristol Myers Squibb; Growth Driven by Milvexian Launch

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering.The table...
July 25, 2025 10:55 ET | Source: Research and Markets

Atrial Fibrillation (AF) Pipeline Market Research Report 2025 | Insights on 10+ Companies and 12+ Drugs in the Pipeline Landscape

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. This report offers in-depth insights into over 10...
June 18, 2025 04:26 ET | Source: Research and Markets

2025 Hypertrophic Cardiomyopathy (HCM) Market View: Analyze 34 Molecules in Development and Discover Trends in Clinical Trials, M&A Deals, and Innovative Therapies

Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Hypertrophic Cardiomyopathy (HCM): Market View" report has been added to ResearchAndMarkets.com's offering.This report offers a data-driven overview...
May 23, 2025 05:42 ET | Source: Research and Markets

Atherosclerosis Market - Global and Regional Analysis and Forecast, 2025-2035 Featuring AstraZeneca, Novartis, Merck, Daiichi Sankyo, GSK, Sanofi, Pfizer, Bayer

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Atherosclerosis Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ...
March 06, 2025 05:54 ET | Source: Research and Markets

Antiarrhythmic Drugs (Beta Blockers, Sodium Channel Blockers) Market Research and Forecasts Report 2025-2030: Rising Prevalence of Cardiovascular Diseases and Advancements in Drug Developments

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Antiarrhythmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Beta Blockers, Sodium Channel Blockers), By Route of...
November 12, 2024 10:53 ET | Source: Research and Markets

North America ACE Inhibitors Market Trends, Competition, Opportunities, 2019-2023 & 2024-2029 with Pfizer, Novartis, and AstraZeneca Leading the $2.93 Billion Industry

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "North America ACE Inhibitors Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
October 30, 2024 11:48 ET | Source: Research and Markets

Angiotensin Converting Enzyme (ACE) Inhibitors Strategic Research Report 2024-2030: Increasing Focus on Lifestyle Management and Preventive Care Sustains Demand f

Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Angiotensin Converting Enzyme (ACE) Inhibitors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
October 14, 2024 10:37 ET | Source: Research and Markets

Atrial Fibrillation Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Atrial Fibrillation - Pipeline...